LUX Lung Special Access Scheme Australia Named Patient Use (NPU)
Clinical trial NCT01209650 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01209650
- Sponsor
- Boehringer Ingelheim
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.